SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CD848C3D0A7EBC087B6070EA485D5B583874309063C7FE736480AC23CA2F9D130E49A929009C96A9D12264DC22732467>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CD848C3D0A7EBC087B6070EA485D5B583874309063C7FE736480AC23CA2F9D130E49A929009C96A9D12264DC22732467
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CD848C3D0A7EBC087B6070EA485D5B583874309063C7FE736480AC23CA2F9D130E49A929009C96A9D12264DC22732467
http://www.w3.org/2000/01/rdf-schema#comment
"RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives."
xsd:string
http://purl.uniprot.org/uniprot/#_F99EA0CAF000A48278E190E2A057F6EAABACA35D2F96125547075ADA440BB6B2E7E8DC8E887236E55546BDD5CCACFA91
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CD848C3D0A7EBC087B6070EA485D5B583874309063C7FE736480AC23CA2F9D130E49A929009C96A9D12264DC22732467
http://purl.uniprot.org/uniprot/Q9BTX6
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CD848C3D0A7EBC087B6070EA485D5B583874309063C7FE736480AC23CA2F9D130E49A929009C96A9D12264DC22732467
http://purl.uniprot.org/uniprot/#_Q9BTX6-mappedCitation-36632846
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CD848C3D0A7EBC087B6070EA485D5B583874309063C7FE736480AC23CA2F9D130E49A929009C96A9D12264DC22732467